OVERVIEW

The North American Interventional Cardiology and Peripheral Vascular Devices Market is expected to reach USD 39 million by 2026, growing at a CAGR of 9.6 per cent during the forecast period. The major factors driving the market include the increasing number of infections and diseases especially in the United States, constant growth in the incidence of cardiovascular conditions which are more prevalent among the elderly population, who have less immunity and are exposed to infectious diseases like COVID-19.Therefore, there is an increasing demand for vascular devices in interventional operations due to its applications in peripheral disease treatment which will positively influence the industry growth.

TABLE OF CONTENT

• • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 North American Interventional Cardiology & Peripheral Vascular Devices Market ? Executive

• • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 North American Interventional Cardiology & Peripheral Vascular Devices Market ?

• • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 North American Interventional Cardiology & Peripheral Vascular Devices Market ? Industry

• • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 North American Interventional Cardiology & Peripheral Vascular Devices Market - Market

• • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 North American Interventional Cardiology & Peripheral Vascular Devices Market - Strategic

• • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 North American Interventional Cardiology & Peripheral Vascular Devices Market ? By Device

• • 8.1 Angioplasty Balloons
  • 8.2 Angioplasty Stents
  • 8.3 Catheters
  • 8.4 Endovascular Aneurysm Repair (EVAR) Stent Grafts
  • 8.5 Inferior Vena Cava (IVC) Filters
  • 8.6 Plaque Modification Devices
  • 8.7 Hemodynamic Flow Alteration Devices
  • 8.8 Accessory Devices
    • 8.8.1 Vascular Closure Devices
    • 8.8.2 Introducer Sheaths
    • 8.8.3 Guide Wires
    • 8.8.4 Balloon Inflation Devices

• 9 North American Interventional Cardiology & Peripheral Vascular Devices Market ? By

• • 9.1 Introduction
  • 9.2 US
  • 9.3 Canada
  • 9.4 Mexico

• 10 North American Interventional Cardiology & Peripheral Vascular Devices Market ? Entropy
  • 10.1 New product launches
  • 10.2 M&A's, collaborations, JVs and partnerships

• 11 North American Interventional Cardiology & Peripheral Vascular Devices Market Company

• • 11.1 Market Share, Company Revenue, Products, M&A, Developments
  • 11.2 Abbott Laboratories
  • 11.3 Medtronic Inc.
  • 11.4 Cook Medical, Inc.
  • 11.5 B. Braun Melsungen AG
  • 11.6 Boston Scientific Corporation
  • 11.7 C. R. Bard, Inc.
  • 11.8 W.L.Gore & Associates, Inc.
  • 11.9 Biotronik SE & Co. Kg
  • 11.10 Cordis Corporation
  • 11.11 Covidien Plc
  • 11.12 Company 11 & more

• 12 North American Interventional Cardiology & Peripheral Vascular Devices Market -

• • 12.1 Sources
  • 12.2 Abbreviations